NCT01666769View on ClinicalTrials.gov

Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 2, 2016

Study Completion Date

February 9, 2016

Conditions
Invasive Candidiasis
Interventions
DRUG

Micafungin

4 mg/kg/day

DRUG

Micafungin

8 mg/kg/day

DRUG

Micafungin

Standard of care Dosing

Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
lead

Kevin Watt

OTHER

NCT01666769 - Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation | Biotech Hunter | Biotech Hunter